Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors ( hPharmaceuticals and Sankyo. For more ...)

Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

h Pharmaceuticals and Sankyo. For more information, please visit the company's web site at www.exelixis.com.

This press release contains forward-looking statements, including without limitation statements related to the safety and potential efficacy of XL999 Words such as "believes," "may," "expects," "plan," "will" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Exelixis' current expectations. Forward-looking statements involve risks and uncertainties. Exelixis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the lengthy, costly and uncertain process of clinical testing of XL999 and the potential failure to demonstrate safety and efficacy and the therapeutic potential of XL999. These and other risk factors are discussed under "Risk Factors" and elsewhere in Exelixis' quarterly report on Form 10-Q for the fiscal quarter ended March 30, 2007 and other filings with the Securities and Exchange Commission. Exelixis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Exelixis, Inc.

Investor Contact: Charles Butler, Director, Corporate Communications,

+1-650-837-7277, cbutler@exelixis.com, or Media Contact: Hal Mackins,

+Corporate

Communications, +1-650-837-7012, hmackins@exelixis.com, both of Exelixis, Inc.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

Post Your Comments:

(Date:12/16/2009)... AARP Illinois Disappointed By Senate Vote Against Lower ... The U.S. Senate on Tuesday night ... Affordable Care Act that would help make prescription ... and legal importation of lower priced drugs from ... and sponsored by Senators Dorgan, Snowe, McCain, Grassley ...

(Date:12/16/2009)... N.J., Dec. 16 MAQUET Cardiovascular ... today announced that it has signed a ... the industry,s leading supply contracting company, for ... Systems. The VASOVIEW products assist healthcare providers ... coronary arteries using only small incisions. This ...

(Date:12/16/2009)... Frost & Sullivan,s ... to speaking at the 2010 International Consumer ... January 9, 2010 in Las Vegas. ... of consumer-based digital health and wellness devices, ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch focuses on patient ...

Breaking Medicine Technology:AARP Illinois Key Vote News Alert 2 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4 Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2 Childhood cancer survivors experience suicidal thoughts decades after diagnosis 59996 1 Childhood cancer survivors experience suicidal thoughts decades after diagnosis 59996 2 Childhood cancer survivors experience suicidal thoughts decades after diagnosis 59996 3 Analysis of Congressional health reform bills highlights similarities differences costs 59991 1 Analysis of Congressional health reform bills highlights similarities differences costs 59991 2 Light Touch Helps Grip of MS Patients 59990 1 Light Touch Helps Grip of MS Patients 59990 2

[0] AARP Illinois Key Vote News Alert [0] MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices [0] Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit

... Ellison, Director of Advanced Medical Center, Licensed to ... Administer ... crisis,of methamphetamine use, Dr. Gregory Ellison, Director of Advanced Medical,Center, has ... rates and is performed on an out-patient (versus,in-patient) basis in 10 ...

... and Focus on ... and Epilepsy Indications -, TOKYO, April 11 ... AMPA-type glutamate,receptor antagonist, in development by Eisai for several ... prophylaxis., The AMPA receptor is widely present in ...

Other Medicine Technology:Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2 Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3 Status of the E2007 (perampanel) Development Program 2 Status of the E2007 (perampanel) Development Program 3 Status of the E2007 (perampanel) Development Program 4

Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate Status of the E2007 (perampanel) Development Program

(Date:12/16/2009)... of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 million ... included in the final Fiscal Year 2010 Defense Appropriations ... research cancers, like colorectal cancer, that are not addressed ... programs run by the U.S. Army Medical Research and ... funding for this new cancer research program was included ...

(Date:12/16/2009)... Wellcome Trust Sanger Institute announce the first comprehensive analyses ... by mutations in the DNA of cancer cells which ... a malignant melanoma and a lung cancer, reveal for ... genomes of two cancers. , Lung cancer causes around ... associated with smoking. The number of mutations found suggest ...

(Date:12/16/2009)... and Encourage Access to Quality, Cost-Effective Care , ... ... Congress have debated the best ways to rein in runaway costs ... An important part of the ongoing discussion includes how to ... providers besides doctors of medicine (MDs) or osteopathy (DOs). In ...

(Date:12/16/2009)... MassBio promote Massachusetts companies through annual marketing campaign , ... ... -- BioSpace unveiled the 2010 Genetown™ Hotbed Campaign ... , , ,Genetown is sponsored by MassBio and ... industries. The campaign places each entity’s brand on an ...

(Date:12/16/2009)... Inc., developers of the AcceleDent System , ... announced Alison Davies as its new Director of ... spent the last fourteen years of her professional ... nine years as a senior manager with ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO ) ,, ...

Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2 Health News:House Creates New Cancer Research Program 3 Health News:Lung cancer and melanoma laid bare 2 Health News:Lung cancer and melanoma laid bare 3 Health News:Lung cancer and melanoma laid bare 4 Health News:Lung cancer and melanoma laid bare 5 Health News:Lung cancer and melanoma laid bare 6 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5 Health News:Thriving Bioscience Region Leaves Its Mark 2 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4

[0] House Creates New Cancer Research Program [1] Lung cancer and melanoma laid bare [1] Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs [0] Thriving Bioscience Region Leaves Its Mark [1] Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom

... When someone speaks to you, do you see what they ... something we hear, but recent studies suggest that we use ... brain treats speech as something we hear, see and even ... Psychological Science , a journal of the Association for Psychological ...

... night,s sleep can do wonders for yourself and ... few more zzz,s in bed can increase the ... from the Better Sleep Council at: http://inr.mediaseed.tv/oneClip_C/?feed=7E0KmviyT9LW2v0hfAgy3p72EXQ2__rd ... and photos for free and unrestricted use at ...

... will enable more time for direct resident ... and increase staff satisfactionPITTSBURGH, Feb. 11 ... Care Partners Management Group (Preferred Care) headquartered ... care in two of its managed skilled ...

... to Move Policymakers to "Thoughtful Dialogue"WASHINGTON, Feb. 11 ... debate the merits of the Medicare Durable Medical ... program, home oxygen leaders call on legislators to ... having on beneficiary services and much needed service-oriented ...

... particularly in the areas of community development, health and ... the economy did not deter the trustees of The ... its fourth-quarter board meeting in December, making the quarter, ... as a whole, the most generous in the foundation,s ...

... Ariz., Feb. 11 eSoles(R) Custom Footbeds, the,world,s leading ... footbeds, today announced that it is an official sponsor ... the 2009 Amgen(R) Tour of,California road cycling race, which ... to Escondido, February 14 - 22, 2009. , ...

Read my lips: Using multiple senses in speech perception AUDIO from Medialink and the Better Sleep Council: Wake Up Your Relationship With Good Sleep This Valentine's Day Preferred Care Partners Management Group Deploys Voice-Assisted Care As Congress Debates Competitive Bidding Program, Home Oxygen Beneficiaries and Providers Left to Cope with 27 Percent Cut to Medicare Home Oxygen Benefit Kresge Foundation Meets Economic Downturn Head on, Awarding a Record $63.6 Million in Grants in Fourth Quarter 2008 eSoles Custom Footbeds Sponsors OUCH Pro Cycling Team in America's Largest Road Cycling Race

Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Most popular size or model....

Straight shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....

Straight shafts with teeth and 6 mm crisscross serrated tying surfaces. Serrated handle with polished finish....

Straight shafts with 1 x 2 teeth. Wide serrated handle with polished finish....

Medicine Products:

Storz Bonn Suturing Forceps McPherson Straight Suturing-Corneal Forceps McCullough Suturing Forceps Sauer Suturing Forceps

( hPharmaceuticals and Sankyo. For more ...)Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors,Health